Cathepsin inhibitors are proving to be a promising area of study regarding the development of therapeutic drugs for an array of common human diseases, and regulating the activity of cathepsins may ...

In the March 1 issue, Drs. Johanna Joyce, Douglas Hanahan and colleagues lend new insight into how broad-spectrum cysteine cathepsin inhibitors combat pancreatic cancer, and provide new data to ...

SOUTH SAN FRANCISCO, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye ...

MENLO PARK, Calif., Nov. 14, 2011 /PRNewswire/ -- Virobay, Inc., a privately held biotechnology firm with a broad portfolio of cysteine protease inhibitors for the ...

Cathepsin Inhibitor Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Cathepsin Inhib. Tuesday, 02 January 2024 12:17 GMT.

MK-0822 is a cathepsin K inhibitor that is being developed for the treatment of osteoporosis in postmenopausal women. As a result, the existence of innovative medicines in the pipeline is projected to ...

image: Non-natural peptide inhibitor in complex with cathepsin S. view more . Credit: Aaron Petruzzella (EPFL) Tumor cells often hijack normal physiological processes to support their growth ...

A team of scientists report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Abeta peptides linked to Alzheimer's disease (AD).

Cathepsin C inhibitor MOD06051 significantly suppressed neutrophil elastase and neutrophil extracellular trap formation in lab models of AAV. In a rat model of MPO-AAV, MOD06051 reduced neutrophil ...

S. Roy Kimura, Ph.D., CEO of Alivexis, commented on the deal: “I am pleased to announce the signing of our licensing and clinical partnership with Melodia for our MOD-A Cathepsin C inhibitor ...

Switzerland’s Melodia Therapeutics has signed a $275 million biobucks deal to get its hands on Alivexis’ preclinical cathepsin C inhibitor. Melodia said it will “rapidly initiate” IND ...